Search Results - Mårdberg, Emelie

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Predictors of drug survival: A cohort study comparing anti‐tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register

    Predictors of drug survival: A cohort study comparing anti‐tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register by Visuri, Isabella, Eriksson, Carl, Olén, Ola, Cao, Yang, Mårdberg, Emelie, Grip, Olof, Gustavsson, Anders, Hjortswang, Henrik, Karling, Pontus, Montgomery, Scott, Myrelid, Pär, Ludvigsson, Jonas F., Halfvarson, Jonas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply

    Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply by Visuri, Isabella, Eriksson, Carl, Olén, Ola, Cao, Yang, Mårdberg, Emelie, Grip, Olof, Gustavsson, Anders, Hjortswang, Henrik, Karling, Pontus, Montgomery, Scott, Myrelid, Pär, Ludvigsson, Jonas F., Halfvarson, Jonas

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: